CHS - Novo Nordisk Psychosocial Research Program

The Canadian Hemophilia Society – Novo Nordisk Canada Psychosocial Research Program was created to engage professionals/graduate students from the allied health disciplines (ie. Nursing, Physiotherapy & Social Work) in research activities addressed to understanding the psychosocial impact of hemophilia and other inherited bleeding disorders and to improve the quality of life of persons and families whose lives are affected by these disorders.

The Research Grants are made possible thanks to generous financial support from Novo Nordisk Canada. Novo Nordisk develops, manufactures and markets products that make a significant difference to patients, the medical profession and society. Novo Nordisk has a leading position within areas such as coagulation disorders, growth disorders and hormone replacement therapy. In addition, Novo Nordisk is also the world leader in diabetes care. The CHS is proud to be in a partnership with Novo Nordisk in order to offer this important Research Program.

Depending upon the number and quality of applications, funding for different amounts is possible, as is the offering of more than one research grant, within however, the allotted total budget stated above.

The major portion of each grant would be to cover the research time for the successful candidate(s), including the time for research assistants. A small amount can be devoted to project expenses.


Agency Name: 
Canadian Hemophilia Society
Contact Name: 
Penny D'Agnone
Grant Amount: 
The primary intent of this program is to offer one or two $20,000 research grants, to a maximum of $40,000 for one year.
Grant Location: 
External Deadline: 
Wednesday, January 16, 2019
Grant Type: 
Grant Area: 
Grant Eligibility: